Gastric antral vascular ectasia, known as GAVE, is a condition in which the blood vessels lining the lower part of the stomach become dilated and fragile, leading to chronic bleeding into the digestive tract. You might know it by its more vivid nickname: watermelon stomach, named for the distinctive red stripes visible during an endoscopy. GAVE tends to fly under the radar because its main symptom, iron-deficiency anemia, develops slowly and can be attributed to many other things before a doctor thinks to look inside the stomach.
How GAVE Got Its Name
The condition was first described in 1953, when a 62-year-old woman with anemia and hidden gastrointestinal blood loss underwent surgery. Her stomach tissue showed what pathologists called “erosive atrophic gastritis with marked veno-capillary ectasia,” essentially inflamed stomach lining with abnormally widened tiny blood vessels. But it took another three decades for the condition to get its memorable nickname. In 1984, researchers coined the term “watermelon stomach” because the rows of red, swollen blood vessels running along the ridges of the stomach’s antrum looked strikingly like the stripes on a watermelon rind.1PubMed Central. Gastric antral vascular ectasia (watermelon stomach)-an enigmatic and often-overlooked cause of gastrointestinal bleeding in the elderly That visual pattern, visible during an upper endoscopy, remains the hallmark way doctors identify GAVE today.
Who Gets GAVE
GAVE has a clear demographic lean. Among patients who do not have cirrhosis, roughly seven in ten are women, and the average age at presentation is around 73.1PubMed Central. Gastric antral vascular ectasia (watermelon stomach)-an enigmatic and often-overlooked cause of gastrointestinal bleeding in the elderly That does not mean younger people or men are immune, but the typical patient is an older woman. GAVE can also appear in people with liver cirrhosis, and when it does, the demographics shift somewhat, since cirrhosis itself affects a broader range of people.
Symptoms and How It Is Found
The frustrating thing about GAVE is how nonspecific the symptoms are. The bleeding is usually slow and steady rather than dramatic, which means many people have no idea they are losing blood at all. Instead, the first clue is often severe iron-deficiency anemia discovered during routine blood work. You might feel fatigued, short of breath, lightheaded, or pale, and your doctor might find your iron and hemoglobin levels are far lower than expected. Some people become dependent on blood transfusions before the underlying cause is identified.
Less commonly, GAVE can cause acute upper gastrointestinal bleeding, which shows up as vomiting blood or passing black, tarry stools. Vague abdominal pain is another symptom, though it is easy to chalk up to something else.1PubMed Central. Gastric antral vascular ectasia (watermelon stomach)-an enigmatic and often-overlooked cause of gastrointestinal bleeding in the elderly Because none of these symptoms point uniquely to GAVE, there is often a considerable delay between when symptoms start and when the diagnosis is made. The condition is ultimately confirmed with an upper endoscopy, where the doctor can see the characteristic watermelon stripes. If the visual pattern is ambiguous, biopsy samples can clinch the diagnosis. Under a microscope, GAVE tissue shows distinctive features including dilated blood vessels, tiny blood clots within those vessels, and overgrowth of the muscle-like tissue surrounding them.2PubMed. Gastric antral vascular ectasia. A histologic and morphometric study of “the watermelon stomach”
What Causes GAVE
The honest answer is that nobody fully understands why GAVE develops. The condition is often described in the medical literature as “enigmatic,” which is a polite way of saying the mechanism is poorly worked out. What researchers do know is that the blood vessels in the stomach’s antrum (the lower section, near the outlet to the small intestine) become abnormally widened, congested, and prone to oozing. Small clots form inside those vessels, and the surrounding tissue thickens. Why this happens in some people and not others remains an open question.
Several theories exist. One focuses on mechanical stress: the antrum is the most muscular part of the stomach, constantly churning to push food along, and it is possible that repeated physical stress on the vessel walls contributes to their deformation. Another theory involves hormonal and vascular factors, since many GAVE patients have conditions that affect blood vessels more broadly. But no single cause has been pinned down, and the research base is still fairly thin.
Conditions That Travel with GAVE
While GAVE can appear on its own, it often shows up alongside other diseases, and the list of associated conditions gives clues about what might be going on in the body. The most commonly discussed link is with liver cirrhosis, though this connection creates more confusion than clarity (more on that below). GAVE is also associated with autoimmune disorders, chronic kidney disease, and bone marrow transplantation.3Journal of Clinical and Translational Hepatology. Patients with gastric antral vascular ectasia (Gave) are at a higher risk of gastrointestinal bleeding in the absence of cirrhosis
The connection with systemic sclerosis (scleroderma) is particularly well documented. In one large cohort of over 2,000 scleroderma patients followed for a median of about four years, roughly one in ten developed GAVE.4PubMed Central. Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival The patients most likely to develop it were those with a specific antibody called anti-RNA polymerase III. Multiple studies have confirmed that this antibody is strongly associated with GAVE in scleroderma patients, with one analysis finding that anti-RNA polymerase III positivity raised the odds of GAVE more than fourfold.5Seminars in Arthritis and Rheumatism. Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies Scleroderma patients with GAVE were also more likely to have gut motility problems, digital ulcers, and scleroderma renal crisis, suggesting that GAVE in this population reflects a broader pattern of blood vessel damage.
The Tricky Distinction from Portal Hypertensive Gastropathy
If you have liver disease, one of the most important things about a GAVE diagnosis is making sure it actually is GAVE and not a look-alike condition called portal hypertensive gastropathy, or PHG. Both cause bleeding from the stomach lining, and both can appear in people with cirrhosis, but they are fundamentally different problems that require different treatments.
PHG is caused by high blood pressure in the portal vein (the vessel that carries blood from the gut to the liver), and it generally responds when that pressure is reduced, whether through medications or procedures. GAVE, on the other hand, does not respond to portal pressure reduction even when portal hypertension happens to be present.6PubMed. Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome Treating GAVE as though it were PHG means subjecting a patient to therapies that will not help and missing the treatments that will.
An experienced endoscopist can usually tell them apart by appearance. GAVE shows the distinctive stripe pattern in the antrum, while PHG tends to produce a mosaic-like pattern across a broader area of the stomach.7PubMed Central. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy Worth noting: more than 70% of GAVE patients do not have cirrhosis or portal hypertension at all, so when GAVE appears in a patient without liver disease, the diagnostic confusion is much less of an issue.6PubMed. Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome
Treatment Options
Endoscopic therapy is the frontline approach for GAVE, and the goal is to seal off the bleeding vessels inside the stomach without surgery. Several techniques exist, and the field has evolved considerably over the past two decades. Pharmacological treatments play a limited role and are generally used as a temporary bridge rather than a definitive fix.8PubMed Central. Beyond Watermelon Stomach: Risk Factors and Treatment of Recurrent Bleeding in Gastric Antral Vascular Ectasia (GAVE)
Argon Plasma Coagulation
Argon plasma coagulation (APC) has long been considered the standard first-line treatment. It works by directing a jet of ionized argon gas at the bleeding vessels, cauterizing them without direct contact. Studies report success rates anywhere from 40% to 100%, depending on how “success” is defined and how long patients are followed. Most people need multiple sessions, with one study reporting an average of about two to three per patient.9PubMed. Argon plasma coagulation for treatment of watermelon stomach
The catch with APC is recurrence. Rates vary widely across studies, from about 10% to nearly 80%.10PubMed Central. Endoscopic treatment for gastric antral vascular ectasia One study of 30 patients found that while most improved and needed fewer transfusions, full endoscopic eradication of the lesions was achieved in only about a third.11Journal of Medicine in Scientific Research. The efficacy of argon plasma coagulation in the treatment of gastric antral vascular ectasia in Mataria teaching hospital APC is generally safe, though potential complications include the formation of abnormal stomach polyps and, rarely, more serious issues like sepsis or tears in the stomach lining.
Endoscopic Band Ligation
Endoscopic band ligation (EBL) is the main alternative to APC, and head-to-head comparisons have generally favored it. EBL works by placing small rubber bands around the abnormal vessels, cutting off blood flow so the tissue withers. A systematic review and meta-analysis of randomized trials found that EBL achieved a higher rate of complete eradication, had lower bleeding recurrence, required fewer treatment sessions, fewer blood transfusions, and fewer hospitalizations compared with APC.12PubMed Central. Endoscopic Band Ligation Versus Argon Plasma Coagulation in the Treatment of Gastric Antral Vascular Ectasia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials A more recent randomized trial confirmed that both techniques improve hemoglobin and reduce transfusion needs, but EBL required significantly fewer sessions to get there.13The Egyptian Journal of Internal Medicine. Safety and efficacy of endoscopic band ligation versus argon plasma coagulation in management of gastric antral vascular ectasia: randomized clinical trial
Despite these advantages, APC remains widely used, in part because it has a longer track record and many gastroenterologists are more experienced with it. The choice often comes down to what is available at a given center and the treating doctor’s expertise.
Radiofrequency Ablation and Cryotherapy
For cases that do not respond to APC or EBL, other endoscopic options exist. Radiofrequency ablation (RFA) uses controlled heat energy to destroy the abnormal vessel layer. A systematic review covering 72 patients treated with RFA found that about three-quarters achieved a clinical response, and serious complications were rare.14PubMed Central. Radiofrequency Ablation for Treatment of Refractory Gastric Antral Vascular Etasia: A Systematic Review of the Literature
Cryotherapy, which uses extreme cold (typically nitrous oxide) to destroy the abnormal tissue, is another emerging option. In one study of 23 patients with GAVE that had resisted other treatments, cryotherapy achieved technical success in all patients, and about 83% were free from needing transfusions six months later. Hemoglobin levels rose by an average of about 2.5 g/dL, and the average monthly transfusion requirement dropped from 1.8 units to 0.3 units. No adverse events were reported.15PubMed Central. Nitrous oxide cryotherapy ablation for refractory gastric antral vascular ectasia These numbers are encouraging, but the evidence base is still small, and cryotherapy is not yet widely available.
When Endoscopy Is Not Enough
A small number of patients have GAVE that keeps coming back despite repeated endoscopic treatments. For these refractory cases, the options narrow. Drug therapies like tranexamic acid, an anti-bleeding medication, have been reported as useful in some cases, though the evidence is limited and they are generally viewed as a stopgap rather than a cure.16PubMed Central. Tranexamic acid may be a useful pharmacotherapy for endoscopically resistant small bowel angiodysplasia
When all else fails, surgical removal of the antrum (antrectomy) remains the definitive treatment. It eliminates the affected tissue entirely and is considered curative, but it is a significant operation with its own risks and is reserved for the most severe cases.17PubMed Central. Transjugular intrahepatic portosystemic shunt as bridge-to-surgery in refractory gastric antral vascular ectasia For patients with both GAVE and liver disease, a procedure to reroute blood flow through the liver (called TIPS) has occasionally been used as a bridge to stabilize the patient before surgery.
Recurrence and Long-Term Outlook
Even after successful treatment, GAVE has a stubborn tendency to come back. A long-term follow-up study of patients treated with endoscopic band ligation found that about half experienced recurrence at an average of around 18 months. Recurrence-free survival dropped from roughly 88% at one year to 44% at two years. The strongest predictor of recurrence was how many blood transfusions a patient had needed before treatment, suggesting that more severe disease at baseline carries a higher risk of returning.18PubMed Central. Long-term follow-up in patients with gastric antral vascular ectasia (GAVE) after treatment with endoscopic band ligation (EBL)
The silver lining is that recurrent GAVE can usually be treated again with the same endoscopic methods. Some patients end up on a cycle of periodic treatments, essentially managing the condition rather than curing it. Regular follow-up with repeat endoscopies and blood work is important even after an initially good response, because recurrence can be detected and treated before anemia becomes severe again.
GAVE in Children
GAVE is overwhelmingly a disease of older adults, and the pediatric literature consists mostly of individual case reports. But it does occur in children, particularly in those with portal hypertension from liver disease. One case report described a 14-year-old boy with cerebral palsy who presented with acute gastrointestinal bleeding and was found to have GAVE on endoscopy. He was managed conservatively without endoscopic treatment.19PubMed. Gastric antral vascular ectasia in children, rare presentation
When treatment is needed in children, the same endoscopic approaches used in adults are adapted. A study comparing EBL and APC in children with portal hypertension and GAVE found that EBL was superior on essentially every measure: fewer treatment sessions, shorter procedure times, less need for transfusions, fewer hospitalizations, and lower recurrence at six months.20PubMed. Gastric antral vascular ectasia in portal hypertensive children: Endoscopic band ligation versus argon plasma coagulation The rarity of pediatric GAVE means that any child diagnosed with it warrants a thorough workup for underlying conditions, since it rarely appears without one.
The Scleroderma Connection
Among all the conditions associated with GAVE, systemic sclerosis deserves particular attention because the link is so strong and has real screening implications. Scleroderma is an autoimmune disease that causes hardening and tightening of the skin and connective tissue, but it also damages blood vessels throughout the body. The gut is commonly affected, leading to problems with motility, reflux, and in some cases GAVE.
Patients with scleroderma who carry the anti-RNA polymerase III antibody are at substantially higher risk. In the large cohort study mentioned earlier, this antibody was found in about a quarter of scleroderma patients who developed GAVE, compared with only 8% of those who did not.4PubMed Central. Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival Patients with GAVE also had more diffuse skin involvement and were more likely to have experienced scleroderma renal crisis. For scleroderma patients, especially those with this antibody profile, unexplained anemia should prompt a look at the stomach sooner rather than later. The overlap between GAVE and the broader vascular damage seen in scleroderma raises questions about whether the two share a common mechanism of vessel injury, but research into that connection is still in its early stages.